about
Cold atmospheric pressure plasma elimination of clinically important single- and mixed-species biofilms.Real-time microfluidic recombinase polymerase amplification for the toxin B gene of Clostridium difficile on a SlipChip platform.Ultra-fast electronic detection of antimicrobial resistance genes using isothermal amplification and Thin Film Transistor sensors.Erratum for Richmond et al., The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner.Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.Novel pyridyl nitrofuranyl isoxazolines show antibacterial activity against multiple drug resistant Staphylococcus species.An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.Recent advances in therapeutic delivery systems of bacteriophage and bacteriophage-encoded endolysins.Retention of virulence following colistin adaptation in Klebsiella pneumoniae is strain-dependent rather than associated with specific mutations.Triaryl Benzimidazoles as a New Class of Antibacterial Agents against Resistant Pathogenic Microorganisms.Thermally triggered release of the bacteriophage endolysin CHAPK and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA)Genome Sequence of vB_AbaS_TRS1, a Viable Prophage Isolated from Acinetobacter baumannii Strain A118.Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains.Establishment of a multi-species biofilm model to evaluate chlorhexidine efficacy.Poly(N-isopropylacrylamide-co-allylamine) (PNIPAM-co-ALA) nanospheres for the thermally triggered release of Bacteriophage K.Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.Evaluation of efficacy of prion reduction filters using blood from an endogenously infected 263K scrapie hamster model.Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.Evaluation of the effectiveness of hydrogen-peroxide-based disinfectants on biofilms formed by Gram-negative pathogens.Revisiting unexploited antibiotics in search of new antibacterial drug candidates: the case of γ-actinorhodin.Comparative Analysis of 37 Acinetobacter Bacteriophages.Visualization of Phage Genomic Data: Comparative Genomics and Publication-Quality Diagrams.C8-Linked Pyrrolobenzodiazepine Monomers with Inverted Building Blocks Show Selective Activity against Multidrug Resistant Gram-Positive Bacteria.Growth media and assay plate material can impact on the effectiveness of cationic biocides and antibiotics against different bacterial species.Evaluation of Novel Process Indicators for Rapid Monitoring of Hydrogen Peroxide Decontamination Processes.Role of bacterial efflux pumps in biofilm formation.Pseudomonas aeruginosa adapts to octenidine in the laboratory and a simulated clinical setting, leading to increased tolerance to chlorhexidine and other biocides.SmvA is an important efflux pump for cationic biocides in Klebsiella pneumoniae and other EnterobacteriaceaeMinor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activityComputational Study Reveals the Molecular Mechanism of the Interaction between the Efflux Inhibitor PAβN and the AdeB Transporter from Acinetobacter baumannii.Evaluation of a Library of FDA-Approved Drugs for Their Ability To Potentiate Antibiotics against Multidrug-Resistant Gram-Negative PathogensMapping the Dynamic Functions and Structural Features of AcrB Efflux Pump Transporter Using Accelerated Molecular Dynamics SimulationsBacterial biofilm formation on indwelling urethral cathetersIdentification of two dihydrodipicolinate synthase isoforms from Pseudomonas aeruginosa that differ in allosteric regulationTemporin L and aurein 2.5 have identical conformations but subtly distinct membrane and antibacterial activitiesEvaluating the level of nitroreductase activity in clinical Klebsiella pneumoniae isolates to support strategies for nitro drug and prodrug developmentMis-annotations of a promising antibiotic target in high-priority gram-negative pathogensSwitching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies
P50
Q33469743-31DBE289-C000-466F-971F-74C8143DE3C4Q35394773-F4437540-8341-44BD-891A-37EA1AD5F9ACQ36372277-3AEA5B11-4539-4843-8F20-653B5B4244FEQ37027328-DD7827B8-ED80-4411-B54B-D159C4A8FA07Q37538712-2AE68A40-80BD-49C2-8A49-F7D3F892C6BEQ38700704-5BB9DD5A-5E89-45D2-B109-AE81FB3305F8Q38715925-22B9E96E-B0DA-4F20-AC72-8469CB1B54F4Q39386520-B558B044-3AC2-415B-B66E-E1185A1E2A70Q40120841-A39418D5-78C6-474D-8C80-D7D808136BE0Q40158062-B64E86CF-7B75-43E2-9554-E9FBCB1F7DC2Q40427118-5A925037-E761-4EF6-9055-6E6826BC1B97Q40507814-DC363787-0C8E-41CC-ACAA-9EB0A6952291Q40783375-FF7C7942-7033-4999-BCCD-6F2EFF709F8EQ40898831-EB73777A-F817-4315-8E2B-25EE1DB4A3B9Q40972499-82B942B3-212C-4114-816F-181638E8FCD8Q41003026-08CB1D1B-6BBB-4D3A-AEE3-4DBD31AB4AF4Q41191389-72BA360E-95F8-4EC6-9BE5-8CA9D80CCDDCQ41998459-491945D0-997A-4F1E-B8D9-5A46D0B2A6E2Q46875412-C3E6CD80-67F3-4C28-9D47-4AEF3C4053DEQ47105053-3154DEE6-30E2-4CDE-A3E1-006BB8A1741BQ47237426-1610C3DA-6CAC-4108-ACA6-FCB585966158Q47602626-4F886565-E988-4858-BFED-402708F8AB99Q48089036-7FABDE50-6629-4DA8-AED9-180ACB513E99Q50061415-D6A3B038-3A00-4518-BDD4-7D6F17E8BDB0Q50642232-A0269AE1-BF9E-4F74-A0DE-6228DCC26C73Q52673702-86A08949-9F28-4CBF-8465-035AC34440E5Q53698887-5205D19E-7FD0-49E2-888D-434A5940C4CCQ61800823-20253C36-124D-4036-BCFB-E30E996E1DCFQ61800920-D95C3675-3688-4D56-A18B-38011B6968E1Q64941178-639732E1-E3BB-4EE0-8A47-A4045A5DDBA0Q66678816-843451BC-C17F-4455-95F6-FD7EB332CF8BQ89545521-67E42F79-1DFE-40D5-8B61-71B59E4FC587Q91965547-86CAC647-01C0-463B-83CB-D854BAB08F92Q92076379-3E0DE0FE-A377-4744-9A3F-A19279B86949Q92266116-15B18769-431C-4185-8AC1-BCD2B9E2FC1FQ92526062-7700DBB4-3B72-44D9-A8C4-164526DA0CDFQ92675676-8467FA8D-143E-43F7-B639-840B5ABB2BA5Q92772590-BF62D314-EA42-405C-ACC5-81C00C250125
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
J Mark Sutton
@en
J Mark Sutton
@nl
type
label
J Mark Sutton
@en
J Mark Sutton
@nl
prefLabel
J Mark Sutton
@en
J Mark Sutton
@nl
P31
P496
0000-0002-2288-0446